Immune Targeting Systems
Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€48—72m (Dealroom.co estimates Mar 2010.)
Great Barrington Massachusetts (HQ)
Authorizing premium user...